GlassScriptPhysician profile
Anthony Francis Boyer
NPI 1720240807
$7,117.79
in general payments reported to CMS, 2019-2025
36 companies · $256 in 2025
The $256 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,642 · 2020: $396 · 2021: $15.70 · 2022: $121 · 2023: $4,517 · 2024: $170 · 2025: $256.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $3,000 · Food and Beverage: $1,078 · Travel and Lodging: $583 · Gift: $283.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $3,000.00 |
| Food and Beverage | $1,077.80 |
| Travel and Lodging | $582.86 |
| Gift | $282.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,931.32 | 2023 | Da Vinci Surgical System |
| Glaxosmithkline, LLC. | $600.78 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Astrazeneca Pharmaceuticals LP | $549.24 | 2019-2025 | Breztri, Andexxa, Tezspire |
| Boehringer Ingelheim Pharmaceuticals, INC. | $318.78 | 2019-2023 | Ofev |
| Genzyme Corporation | $267.06 | 2019-2025 | |
| Mylan Specialty L.P. | $157.54 | 2019 | |
| Grifols USA, LLC | $111.38 | 2019-2025 | Prolastin-C Liquid |
| Actelion Pharmaceuticals US, INC. | $108.87 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $99.52 | 2019-2024 | Dupixent |
| Insmed, INC. | $96.93 | 2019-2023 | Arikayce |
| Electromed, INC. | $78.78 | 2019-2025 | Smartvest |
| Merck Sharp & Dohme LLC | $76.21 | 2019-2023 | Dificid, Recarbrio, Zerbaxa |
| Janssen Pharmaceuticals, INC | $73.78 | 2020-2023 | Xarelto |
| Mayne Pharma Commercial LLC | $71.83 | 2019 | |
| Novartis Pharmaceuticals Corporation | $53.74 | 2019 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| United Therapeutics Corporation | $52.55 | 2023 | Tyvaso |
| Shire North American Group INC | $51.03 | 2019 | |
| Portola Pharmaceuticals, LLC | $38.46 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $36.52 | 2023-2024 | Glassia |
| Mallinckrodt Enterprises LLC | $35.24 | 2019 | |
| Allergan, INC. | $29.47 | 2019 | |
| Baxter Healthcare | $26.62 | 2025 | Hillrom - Vest System Model 105 Home Care |
| Genentech USA, INC. | $26.13 | 2019 | |
| Advanced Respiratory, INC | $25.82 | 2019 | |
| Amgen INC. | $25.00 | 2023 | Tezspire |
| Jazz Pharmaceuticals INC. | $23.11 | 2019 | |
| Vifor Pharma, INC. | $22.86 | 2024 | Zemaira |
| Circassia INC. | $19.14 | 2019 | |
| Tetraphase Pharmaceuticals, INC. | $17.70 | 2019 | |
| Tactile Systems Technology INC | $15.70 | 2021 | |
| Medtronic, INC. | $15.45 | 2023 | Illumisite |
| Organogenesis INC. | $14.24 | 2019 | |
| Pfizer INC. | $13.53 | 2019 | |
| Breathe Technologies, INC. | $13.52 | 2019 | |
| Philips North America LLC | $13.52 | 2024 | (Ak6) Vest Therapy |
| Inogen, INC. | $6.42 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Boyer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.